Neurological Complications after Transcatheter Aortic Valve Implantation Procedure
DOI:
https://doi.org/10.15225/PNN.2024.13.1.6Keywords
aortic stenosis, primary valvular heart disease, stroke, transcatheter aortic valve implantationAbstract
Aortic stenosis is the most common primary valvular heart disease in both Europe and North America. In patients with symptomatic severe aortic stenosis, early surgical treatment is recommended because of the very poor prognosis and the lack of effect of conservative treatment on the natural course of this heart defect. The primary treatment options for severe aortic stenosis are surgical aortic valve replacement and transcatheter aortic valve implantation. Complication rates between therapeutic procedures used vary according to the group to which the patient has been assigned by health care professionals on the basis of the risk of possible complications or mortality. Neurological symptoms that are consequences of transcatheter aortic valve implantation remain a major challenge for providers. The aim of this study was to assess the risk of neurological complications after transcatheter aortic valve implantation. (JNNN 2024;13(1):36–41)
References
Vahanian A., Beyersdorf F., Praz F. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.
Steiner J.M., Cooper S., Kirkpatrick J.N. Palliative care in end-stage valvular heart disease. Heart. 2017;103(16):1233–1237.
Mack M.J., Leon M.B., Thourani V.H. et al. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med. 2023;389(21):1949–1960.
Svensson L.G., Adams D.H., Bonow R.O. et al. Aortic valve and ascending aorta guidelines for management and quality measures: executive summary. Ann Thorac Surg. 2013;95(4):1491–1505.
Mack M.J., Leon M.B., Thourani V.H. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695–1705.
Popma J.J., Deeb G.M., Yakubov S.J. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1706–1715.
Forrest J.K., Deeb G.M., Yakubov S.J. et al. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. J Am Coll Cardiol. 2022;79(9):882–896.
Leon M.B., Smith C.R., Mack M.J. et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609–1620.
Durko A.P., Reardon M.J., Kleiman N.S. et al. Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018;72(18):2109–2119.
Smith C.R., Leon M.B., Mack M.J. et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198.
Adams D.H., Popma J.J., Reardon M.J. et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–1798.
Huded C.P., Tuzcu E.M., Krishnaswamy A. et al. Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. JAMA. 2019;321(23):2306–2315.
Wang C., Han J., Lu L., Qiu J., Fu Y., Zheng J. The efficacy of different types of cerebral embolic protection device during transcatheter aortic valve implantation: a meta-analysis. Front Cardiovasc Med. 2024;11:1205943.
Kapadia S.R., Kodali S., Makkar R. et al. Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2017;69(4):367–377.
Nazif T.M., Moses J., Sharma R. et al. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II. JACC Cardiovasc Interv. 2021;14(5):515–527.
Levi A., Linder M., Seiffert M. et al. The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR. JACC Cardiovasc Interv. 2024;17(5):666–677.
Kapadia S.R., Makkar R., Leon M. et al. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. N Engl J Med. 2022;387(14):1253–1263.
Nijenhuis V.J., Brouwer J., Delewi R. et al. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. N Engl J Med. 2020;382(18):1696–1707.
Guedeney P., Roule V., Mesnier J. et al. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2023;9(3):251–261.
Brouwer J., Nijenhuis V.J., Delewi R. et al. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. N Engl J Med. 2020;383(15):1447–1457.
Benesch C., Glance L.G., Derdeyn C.P. et al. Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association. Circulation. 2021;143(19):e923–e946.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 108
Number of citations: 0